Los Angeles based technology venture fund
Business Model:
Revenue: $0
Employees: 0-0
Address: 4700 Wilshire Blvd
City: Los Angeles
State: CA
Zip: 90010
Country: US
OCV Management LLC is a Los Angeles based investment adviser co-founded by Richard Ressler and Mark Yung in 2016. The firm leverages an investment strategy deployed successfully since 1993 and a team of seasoned professionals who have worked together for an average of 19 years. OCV invests in companies with differentiated technologies and compelling target markets, with the objective of assisting companies create sustainable long-term value. As partners, OCV provides operational and financial expertise through its experienced principals, who have proven success as entrepreneurs, business leaders and investors across a variety of sectors including technology, healthcare, industrials, real estate and finance. OCV invests across all stages of a company’s growth cycle, and finds creative investment solutions to fit a company’s needs. For more information, visit http://www.ocvpartners.com.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2022 | Ozette Technologies | Series A | 0 |
8/2019 | Finch Therapeutics | Series C | 0 |
4/2020 | SafeBreach | Series C | 0 |
3/2019 | Ossio | Series A | 22M |
11/2021 | Rad AI | Series A | 0 |
1/2022 | Ockam | Series A | 0 |
6/2018 | Precision BioSciences | Series B | 0 |
9/2020 | Finch Therapeutics | Series D | 0 |
7/2021 | ByHeart | Series B | 0 |
4/2020 | ByHeart | Series A | 0 |
4/2021 | Orca AI | Seed Round | 0 |
7/2020 | Praxis Precision Medicines | Series C | 0 |
8/2019 | Figure8 | Series A | 40M |
9/2018 | Invoice2go | Series C | 10M |
7/2022 | Ozette Technologies | Series A | 0 |
1/2022 | Ockam | Series A | 0 |
11/2021 | Rad AI | Series A | 0 |
7/2021 | ByHeart | Series B | 0 |
4/2021 | Orca AI | Seed Round | 0 |
9/2020 | Finch Therapeutics | Series D | 0 |
7/2020 | Praxis Precision Medicines | Series C | 0 |
4/2020 | ByHeart | Series A | 0 |
4/2020 | SafeBreach | Series C | 0 |
8/2019 | Finch Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|